OSI INITIATES PHASE I CLINICAL TRIAL OF PSN357.: An article from: Worldwide Biotech

This digital document is an article from Worldwide Biotech, published by Worldwide Videotex on September 1, 2005. The length of the article is 698 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: OSI INITIATES PHASE I CLINICAL TRIAL OF PSN357.
Publication:Worldwide Biotech (Newsletter)
Date: September 1, 2005
Publisher: Worldwide Videotex
Volume: 17 Issue: 9 Page: NA

Distributed by Thomson Gale